Australia - Inggris - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 100 mg - tablet, modified release - excipient ingredients: hyetellose; povidone; hypromellose; magnesium stearate; purified talc; titanium dioxide; iron oxide black; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 60 mg - tablet, modified release - excipient ingredients: hyetellose; magnesium stearate; purified talc; lactose monohydrate; hypromellose; povidone; titanium dioxide; sunset yellow fcf aluminium lake; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 30 mg - tablet, modified release - excipient ingredients: povidone; hyetellose; magnesium stearate; hypromellose; lactose monohydrate; purified talc; titanium dioxide; indigo carmine; sunset yellow fcf; erythrosine; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - morphine sulfate pentahydrate, quantity: 10 mg/ml - injection, suspension - excipient ingredients: dioleoylphosphatidylcholine; dipalmitoylphosphatidylglycerol; cholesterol; triolein; tricaprylin; sodium chloride; dilute hydrochloric acid; water for injections - for the relief of post-operative pain following major orthopaedic, abdominal, or pelvic surgery via the lumbar epidural route at a maximum recommended dose of 10 mg. appropriate monitoring must be maintained for at least 48 hours - see precautions.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate, quantity: 30 mg - capsule, modified release - excipient ingredients: macrogol 6000; gelatin; purified talc; titanium dioxide; magnesium stearate; hydrogenated vegetable oil; sodium lauryl sulfate; indigo carmine; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; industrial methylated spirit; iron oxide black; shellac; sulfuric acid; ammonia - ms mono capsules are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. ms mono capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. ms mono capsules are not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate, quantity: 60 mg - capsule, modified release - excipient ingredients: iron oxide red; sodium lauryl sulfate; indigo carmine; magnesium stearate; titanium dioxide; purified talc; macrogol 6000; iron oxide yellow; gelatin; hydrogenated vegetable oil; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; industrial methylated spirit; iron oxide black; shellac; sulfuric acid; ammonia - ms mono capsules are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. ms mono capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. ms mono capsules are not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate, quantity: 90 mg - capsule, modified release - excipient ingredients: purified talc; iron oxide red; titanium dioxide; magnesium stearate; sodium lauryl sulfate; iron oxide black; macrogol 6000; erythrosine; hydrogenated vegetable oil; gelatin; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; industrial methylated spirit; shellac; sulfuric acid; ammonia - ms mono capsules are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. ms mono capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. ms mono capsules are not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate, quantity: 120 mg - capsule, modified release - excipient ingredients: iron oxide yellow; sodium lauryl sulfate; purified talc; titanium dioxide; magnesium stearate; gelatin; indigo carmine; iron oxide black; macrogol 6000; hydrogenated vegetable oil; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; industrial methylated spirit; shellac; sulfuric acid; ammonia - ms mono capsules are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long-term treatment. ms mono capsules are not indicated for use in chronic non-cancer pain other than in exceptional circumstances. ms mono capsules are not indicated as an as-needed (prn) analgesia.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - morphine sulfate pentahydrate -